HEADER APOPTOSIS 14-DEC-17 6BW8 TITLE MCL-1 COMPLEXED WITH SMALL MOLECULES COMPND MOL_ID: 1; COMPND 2 MOLECULE: INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL- COMPND 3 1; COMPND 4 CHAIN: A, B, C, D; COMPND 5 SYNONYM: BCL-2-LIKE PROTEIN 3,BCL2-L-3,BCL-2-RELATED PROTEIN COMPND 6 EAT/MCL1,MCL1/EAT; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MCL1, BCL2L3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MCL-1 INHIBITOR, CANCER, STRUCTURE-BASED DESIGN, DRUG DISCOVERY, KEYWDS 2 APOPTOSIS EXPDTA X-RAY DIFFRACTION AUTHOR B.ZHAO REVDAT 5 04-OCT-23 6BW8 1 REMARK REVDAT 4 04-DEC-19 6BW8 1 REMARK REVDAT 3 04-APR-18 6BW8 1 JRNL REVDAT 2 21-MAR-18 6BW8 1 JRNL REVDAT 1 31-JAN-18 6BW8 0 JRNL AUTH S.SHAW,Z.BIAN,B.ZHAO,J.C.TARR,N.VEERASAMY,K.O.JEON,J.BELMAR, JRNL AUTH 2 A.L.ARNOLD,S.A.FOGARTY,E.PERRY,J.L.SENSINTAFFAR,D.V.CAMPER, JRNL AUTH 3 O.W.ROSSANESE,T.LEE,E.T.OLEJNICZAK,S.W.FESIK JRNL TITL OPTIMIZATION OF POTENT AND SELECTIVE TRICYCLIC INDOLE JRNL TITL 2 DIAZEPINONE MYELOID CELL LEUKEMIA-1 INHIBITORS USING JRNL TITL 3 STRUCTURE-BASED DESIGN. JRNL REF J. MED. CHEM. V. 61 2410 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 29323899 JRNL DOI 10.1021/ACS.JMEDCHEM.7B01155 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.12_2829: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 54.420 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.5 REMARK 3 NUMBER OF REFLECTIONS : 19827 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.238 REMARK 3 R VALUE (WORKING SET) : 0.235 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.770 REMARK 3 FREE R VALUE TEST SET COUNT : 1943 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 26.0584 - 6.9502 0.90 1450 158 0.1990 0.1924 REMARK 3 2 6.9502 - 5.5339 0.85 1356 155 0.2491 0.3035 REMARK 3 3 5.5339 - 4.8395 0.83 1296 139 0.2296 0.2594 REMARK 3 4 4.8395 - 4.3993 0.83 1331 142 0.2131 0.2593 REMARK 3 5 4.3993 - 4.0853 0.83 1304 147 0.2371 0.2364 REMARK 3 6 4.0853 - 3.8452 0.82 1295 145 0.2324 0.2200 REMARK 3 7 3.8452 - 3.6532 0.82 1310 143 0.2465 0.2795 REMARK 3 8 3.6532 - 3.4945 0.82 1290 135 0.2473 0.2556 REMARK 3 9 3.4945 - 3.3603 0.80 1265 146 0.2514 0.2797 REMARK 3 10 3.3603 - 3.2446 0.79 1221 129 0.2544 0.3061 REMARK 3 11 3.2446 - 3.1433 0.78 1259 143 0.2609 0.2754 REMARK 3 12 3.1433 - 3.0536 0.77 1169 129 0.2712 0.2700 REMARK 3 13 3.0536 - 2.9733 0.75 1199 129 0.2812 0.3064 REMARK 3 14 2.9733 - 2.9009 0.69 1099 131 0.2845 0.2591 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.420 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 4993 REMARK 3 ANGLE : 0.992 6759 REMARK 3 CHIRALITY : 0.057 718 REMARK 3 PLANARITY : 0.006 847 REMARK 3 DIHEDRAL : 5.880 2904 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 8.2411 27.7770 26.0701 REMARK 3 T TENSOR REMARK 3 T11: 0.2684 T22: 0.3204 REMARK 3 T33: 0.1572 T12: -0.0327 REMARK 3 T13: 0.0329 T23: 0.0062 REMARK 3 L TENSOR REMARK 3 L11: 0.5688 L22: 0.4620 REMARK 3 L33: 0.5861 L12: 0.0849 REMARK 3 L13: 0.1665 L23: 0.1041 REMARK 3 S TENSOR REMARK 3 S11: 0.0672 S12: -0.1104 S13: -0.0791 REMARK 3 S21: 0.0708 S22: -0.0619 S23: -0.0214 REMARK 3 S31: 0.1060 S32: -0.1522 S33: 0.0223 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6BW8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JAN-18. REMARK 100 THE DEPOSITION ID IS D_1000231690. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-OCT-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19873 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.08300 REMARK 200 R SYM (I) : 0.06800 REMARK 200 FOR THE DATA SET : 12.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 76.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.32800 REMARK 200 R SYM FOR SHELL (I) : 0.38800 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4ZBF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.12 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20%-30% PEG3350, MAGNESIUM CHLORIDE, REMARK 280 BIS-TRIS, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 67.69850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 170 REMARK 465 ASP A 171 REMARK 465 VAL A 321 REMARK 465 GLU A 322 REMARK 465 ASP A 323 REMARK 465 LEU A 324 REMARK 465 GLU A 325 REMARK 465 GLY A 326 REMARK 465 GLY A 327 REMARK 465 ALA B 170 REMARK 465 ASP B 171 REMARK 465 THR B 196 REMARK 465 LYS B 197 REMARK 465 GLU B 322 REMARK 465 ASP B 323 REMARK 465 LEU B 324 REMARK 465 GLU B 325 REMARK 465 GLY B 326 REMARK 465 GLY B 327 REMARK 465 ALA C 170 REMARK 465 ASP C 171 REMARK 465 ASP C 195 REMARK 465 THR C 196 REMARK 465 SER C 202 REMARK 465 GLY C 203 REMARK 465 VAL C 321 REMARK 465 GLU C 322 REMARK 465 ASP C 323 REMARK 465 LEU C 324 REMARK 465 GLU C 325 REMARK 465 GLY C 326 REMARK 465 GLY C 327 REMARK 465 ALA D 170 REMARK 465 ASP D 171 REMARK 465 VAL D 321 REMARK 465 GLU D 322 REMARK 465 ASP D 323 REMARK 465 LEU D 324 REMARK 465 GLU D 325 REMARK 465 GLY D 326 REMARK 465 GLY D 327 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 174 CG CD1 CD2 REMARK 470 LYS A 194 CG CD CE NZ REMARK 470 MET A 199 CE REMARK 470 ARG A 201 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 208 CG CD CE NZ REMARK 470 ASN A 282 CG OD1 ND2 REMARK 470 LYS A 308 CD CE NZ REMARK 470 GLU B 173 CG CD OE1 OE2 REMARK 470 ASP B 195 CG OD1 OD2 REMARK 470 MET B 199 CG SD CE REMARK 470 LYS B 244 CD CE NZ REMARK 470 SER B 255 OG REMARK 470 ARG B 310 CG CD NE CZ NH1 NH2 REMARK 470 LEU C 174 CD1 CD2 REMARK 470 LYS C 208 CE NZ REMARK 470 LYS C 276 CA CG CD CE NZ REMARK 470 LYS C 279 CD CE NZ REMARK 470 LEU C 306 CG CD1 CD2 REMARK 470 THR D 196 OG1 CG2 REMARK 470 MET D 199 SD CE REMARK 470 SER D 202 OG REMARK 470 SER D 245 CB OG REMARK 470 LYS D 279 CD CE NZ REMARK 470 ARG D 310 CG CD NE CZ NH1 NH2 REMARK 470 GLU D 317 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O VAL C 297 OG1 THR C 301 2.13 REMARK 500 NH2 ARG A 176 O ARG A 201 2.15 REMARK 500 N LYS A 238 OD2 ASP A 242 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 195 159.47 65.23 REMARK 500 PRO A 198 -153.76 -75.75 REMARK 500 SER A 255 -131.15 35.79 REMARK 500 ASN A 282 -4.00 54.39 REMARK 500 ARG B 215 -70.99 -53.75 REMARK 500 SER B 255 -76.13 -71.84 REMARK 500 GLN B 283 50.53 -117.87 REMARK 500 ARG B 310 -41.57 65.06 REMARK 500 PHE B 319 59.23 -108.30 REMARK 500 GLN C 283 52.29 -118.64 REMARK 500 ASP D 195 103.63 60.04 REMARK 500 LYS D 244 69.61 -68.62 REMARK 500 SER D 245 0.03 -172.37 REMARK 500 SER D 255 -157.92 -80.53 REMARK 500 ASP D 256 86.17 52.72 REMARK 500 GLN D 283 53.83 -142.51 REMARK 500 ARG D 310 -94.49 70.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ECM A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ECM B 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ECM C 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ECM D 400 DBREF 6BW8 A 172 327 UNP Q07820 MCL1_HUMAN 172 327 DBREF 6BW8 B 172 327 UNP Q07820 MCL1_HUMAN 172 327 DBREF 6BW8 C 172 327 UNP Q07820 MCL1_HUMAN 172 327 DBREF 6BW8 D 172 327 UNP Q07820 MCL1_HUMAN 172 327 SEQADV 6BW8 ALA A 170 UNP Q07820 EXPRESSION TAG SEQADV 6BW8 ASP A 171 UNP Q07820 EXPRESSION TAG SEQADV 6BW8 ALA B 170 UNP Q07820 EXPRESSION TAG SEQADV 6BW8 ASP B 171 UNP Q07820 EXPRESSION TAG SEQADV 6BW8 ALA C 170 UNP Q07820 EXPRESSION TAG SEQADV 6BW8 ASP C 171 UNP Q07820 EXPRESSION TAG SEQADV 6BW8 ALA D 170 UNP Q07820 EXPRESSION TAG SEQADV 6BW8 ASP D 171 UNP Q07820 EXPRESSION TAG SEQRES 1 A 158 ALA ASP ASP GLU LEU TYR ARG GLN SER LEU GLU ILE ILE SEQRES 2 A 158 SER ARG TYR LEU ARG GLU GLN ALA THR GLY ALA LYS ASP SEQRES 3 A 158 THR LYS PRO MET GLY ARG SER GLY ALA THR SER ARG LYS SEQRES 4 A 158 ALA LEU GLU THR LEU ARG ARG VAL GLY ASP GLY VAL GLN SEQRES 5 A 158 ARG ASN HIS GLU THR ALA PHE GLN GLY MET LEU ARG LYS SEQRES 6 A 158 LEU ASP ILE LYS ASN GLU ASP ASP VAL LYS SER LEU SER SEQRES 7 A 158 ARG VAL MET ILE HIS VAL PHE SER ASP GLY VAL THR ASN SEQRES 8 A 158 TRP GLY ARG ILE VAL THR LEU ILE SER PHE GLY ALA PHE SEQRES 9 A 158 VAL ALA LYS HIS LEU LYS THR ILE ASN GLN GLU SER CYS SEQRES 10 A 158 ILE GLU PRO LEU ALA GLU SER ILE THR ASP VAL LEU VAL SEQRES 11 A 158 ARG THR LYS ARG ASP TRP LEU VAL LYS GLN ARG GLY TRP SEQRES 12 A 158 ASP GLY PHE VAL GLU PHE PHE HIS VAL GLU ASP LEU GLU SEQRES 13 A 158 GLY GLY SEQRES 1 B 158 ALA ASP ASP GLU LEU TYR ARG GLN SER LEU GLU ILE ILE SEQRES 2 B 158 SER ARG TYR LEU ARG GLU GLN ALA THR GLY ALA LYS ASP SEQRES 3 B 158 THR LYS PRO MET GLY ARG SER GLY ALA THR SER ARG LYS SEQRES 4 B 158 ALA LEU GLU THR LEU ARG ARG VAL GLY ASP GLY VAL GLN SEQRES 5 B 158 ARG ASN HIS GLU THR ALA PHE GLN GLY MET LEU ARG LYS SEQRES 6 B 158 LEU ASP ILE LYS ASN GLU ASP ASP VAL LYS SER LEU SER SEQRES 7 B 158 ARG VAL MET ILE HIS VAL PHE SER ASP GLY VAL THR ASN SEQRES 8 B 158 TRP GLY ARG ILE VAL THR LEU ILE SER PHE GLY ALA PHE SEQRES 9 B 158 VAL ALA LYS HIS LEU LYS THR ILE ASN GLN GLU SER CYS SEQRES 10 B 158 ILE GLU PRO LEU ALA GLU SER ILE THR ASP VAL LEU VAL SEQRES 11 B 158 ARG THR LYS ARG ASP TRP LEU VAL LYS GLN ARG GLY TRP SEQRES 12 B 158 ASP GLY PHE VAL GLU PHE PHE HIS VAL GLU ASP LEU GLU SEQRES 13 B 158 GLY GLY SEQRES 1 C 158 ALA ASP ASP GLU LEU TYR ARG GLN SER LEU GLU ILE ILE SEQRES 2 C 158 SER ARG TYR LEU ARG GLU GLN ALA THR GLY ALA LYS ASP SEQRES 3 C 158 THR LYS PRO MET GLY ARG SER GLY ALA THR SER ARG LYS SEQRES 4 C 158 ALA LEU GLU THR LEU ARG ARG VAL GLY ASP GLY VAL GLN SEQRES 5 C 158 ARG ASN HIS GLU THR ALA PHE GLN GLY MET LEU ARG LYS SEQRES 6 C 158 LEU ASP ILE LYS ASN GLU ASP ASP VAL LYS SER LEU SER SEQRES 7 C 158 ARG VAL MET ILE HIS VAL PHE SER ASP GLY VAL THR ASN SEQRES 8 C 158 TRP GLY ARG ILE VAL THR LEU ILE SER PHE GLY ALA PHE SEQRES 9 C 158 VAL ALA LYS HIS LEU LYS THR ILE ASN GLN GLU SER CYS SEQRES 10 C 158 ILE GLU PRO LEU ALA GLU SER ILE THR ASP VAL LEU VAL SEQRES 11 C 158 ARG THR LYS ARG ASP TRP LEU VAL LYS GLN ARG GLY TRP SEQRES 12 C 158 ASP GLY PHE VAL GLU PHE PHE HIS VAL GLU ASP LEU GLU SEQRES 13 C 158 GLY GLY SEQRES 1 D 158 ALA ASP ASP GLU LEU TYR ARG GLN SER LEU GLU ILE ILE SEQRES 2 D 158 SER ARG TYR LEU ARG GLU GLN ALA THR GLY ALA LYS ASP SEQRES 3 D 158 THR LYS PRO MET GLY ARG SER GLY ALA THR SER ARG LYS SEQRES 4 D 158 ALA LEU GLU THR LEU ARG ARG VAL GLY ASP GLY VAL GLN SEQRES 5 D 158 ARG ASN HIS GLU THR ALA PHE GLN GLY MET LEU ARG LYS SEQRES 6 D 158 LEU ASP ILE LYS ASN GLU ASP ASP VAL LYS SER LEU SER SEQRES 7 D 158 ARG VAL MET ILE HIS VAL PHE SER ASP GLY VAL THR ASN SEQRES 8 D 158 TRP GLY ARG ILE VAL THR LEU ILE SER PHE GLY ALA PHE SEQRES 9 D 158 VAL ALA LYS HIS LEU LYS THR ILE ASN GLN GLU SER CYS SEQRES 10 D 158 ILE GLU PRO LEU ALA GLU SER ILE THR ASP VAL LEU VAL SEQRES 11 D 158 ARG THR LYS ARG ASP TRP LEU VAL LYS GLN ARG GLY TRP SEQRES 12 D 158 ASP GLY PHE VAL GLU PHE PHE HIS VAL GLU ASP LEU GLU SEQRES 13 D 158 GLY GLY HET ECM A 400 50 HET ECM B 400 50 HET ECM C 400 50 HET ECM D 400 50 HETNAM ECM 7-{8-CHLORO-11-[3-(4-CHLORO-3,5-DIMETHYLPHENOXY) HETNAM 2 ECM PROPYL]-1-OXO-7-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)-4,5- HETNAM 3 ECM DIHYDRO-1H-[1,4]DIAZEPINO[1,2-A]INDOL-2(3H)-YL}-1- HETNAM 4 ECM METHYL-1H-INDOLE-3-CARBOXYLIC ACID FORMUL 5 ECM 4(C39 H39 CL2 N5 O4) HELIX 1 AA1 ASP A 172 GLY A 192 1 21 HELIX 2 AA2 SER A 202 HIS A 224 1 23 HELIX 3 AA3 HIS A 224 ASP A 236 1 13 HELIX 4 AA4 ASN A 239 SER A 255 1 17 HELIX 5 AA5 ASN A 260 ILE A 281 1 22 HELIX 6 AA6 GLN A 283 SER A 285 5 3 HELIX 7 AA7 CYS A 286 GLN A 309 1 24 HELIX 8 AA8 GLY A 311 PHE A 319 1 9 HELIX 9 AA9 GLU B 173 GLY B 192 1 20 HELIX 10 AB1 SER B 202 HIS B 224 1 23 HELIX 11 AB2 HIS B 224 ASP B 236 1 13 HELIX 12 AB3 ASN B 239 SER B 245 1 7 HELIX 13 AB4 LEU B 246 SER B 255 1 10 HELIX 14 AB5 ASN B 260 ILE B 281 1 22 HELIX 15 AB6 GLN B 283 SER B 285 5 3 HELIX 16 AB7 CYS B 286 LYS B 308 1 23 HELIX 17 AB8 GLY B 311 PHE B 319 1 9 HELIX 18 AB9 GLU C 173 GLY C 192 1 20 HELIX 19 AC1 THR C 205 HIS C 224 1 20 HELIX 20 AC2 HIS C 224 ASP C 236 1 13 HELIX 21 AC3 ASN C 239 SER C 245 1 7 HELIX 22 AC4 LEU C 246 ASP C 256 1 11 HELIX 23 AC5 ASN C 260 ILE C 281 1 22 HELIX 24 AC6 GLN C 283 SER C 285 5 3 HELIX 25 AC7 CYS C 286 GLN C 309 1 24 HELIX 26 AC8 GLY C 311 HIS C 320 1 10 HELIX 27 AC9 GLU D 173 GLY D 192 1 20 HELIX 28 AD1 SER D 202 ARG D 222 1 21 HELIX 29 AD2 HIS D 224 ASP D 236 1 13 HELIX 30 AD3 ASN D 239 LYS D 244 1 6 HELIX 31 AD4 LEU D 246 SER D 255 1 10 HELIX 32 AD5 ASN D 260 ILE D 281 1 22 HELIX 33 AD6 GLN D 283 SER D 285 5 3 HELIX 34 AD7 CYS D 286 GLN D 309 1 24 HELIX 35 AD8 GLY D 311 PHE D 319 1 9 SITE 1 AC1 13 HIS A 224 ALA A 227 PHE A 228 MET A 231 SITE 2 AC1 13 MET A 250 VAL A 253 ASN A 260 ARG A 263 SITE 3 AC1 13 THR A 266 LEU A 267 PHE A 270 GLY A 271 SITE 4 AC1 13 HIS B 320 SITE 1 AC2 13 ARG A 310 ALA B 227 PHE B 228 MET B 231 SITE 2 AC2 13 MET B 250 VAL B 253 PHE B 254 VAL B 258 SITE 3 AC2 13 ASN B 260 ARG B 263 THR B 266 LEU B 267 SITE 4 AC2 13 PHE B 270 SITE 1 AC3 15 HIS A 252 HIS C 224 ALA C 227 PHE C 228 SITE 2 AC3 15 MET C 231 VAL C 249 VAL C 253 PHE C 254 SITE 3 AC3 15 ASN C 260 ARG C 263 THR C 266 LEU C 267 SITE 4 AC3 15 PHE C 270 GLY C 271 ILE C 294 SITE 1 AC4 9 ALA D 227 PHE D 228 MET D 231 MET D 250 SITE 2 AC4 9 VAL D 253 ARG D 263 LEU D 267 PHE D 270 SITE 3 AC4 9 GLY D 271 CRYST1 39.178 135.397 95.750 90.00 90.12 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025525 0.000000 0.000053 0.00000 SCALE2 0.000000 0.007386 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010444 0.00000